Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
Eurosurveillance, Volume 16, Issue 22, 02 June 2011
Surveillance and outbreak reports
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011
S Vaux<SUP>1</SUP>, A Carbonne<SUP>2</SUP>, J M Thiolet<SUP>1</SUP>, V Jarlier<SUP>3</SUP>, B Coignard (
)<SUP>1</SUP>, RAISIN and Expert Laboratories Groups<SUP>4</SUP>
Citation style for this article: Vaux S, Carbonne A, Thiolet JM, Jarlier V, Coignard B, RAISIN and Expert Laboratories Groups. Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011 . Euro Surveill. 2011;16(22)
ii=19880. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19880
Date of submission: 17 December 2010 <HR>Emergence of carbapenemase-producing Enterobacteriaceae (CPE) is currently a major public health concern worldwide. This study showed that 53 episodes of CPE infection or colonisation have been notified by French healthcare facilities since 2004. A sharp increase in the number of notifications was observed in the last three years. Oxacillinase (OXA)-48 and Klebsiella pneumoniae carbapenemase (KPC) beta-lactamases were the most frequent enzymes reported in these episodes. The index cases in most episodes were patients with a history of hospitalisation abroad within the previous year. Around a third of the episodes (n=18) led to secondary transmission in hospitals but most of them were controlled due to reinforced measures. Reinforcement of screening and control measures at national level when there is cross-border transfer of patients, along with overall reinforcement of infection control and antimicrobial stewardship worldwide, is urgently needed to contain the spread of CPE.
- ------
Eurosurveillance, Volume 16, Issue 22, 02 June 2011
Surveillance and outbreak reports
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011
S Vaux<SUP>1</SUP>, A Carbonne<SUP>2</SUP>, J M Thiolet<SUP>1</SUP>, V Jarlier<SUP>3</SUP>, B Coignard (
- French Institute for Public Health Surveillance (Institut de Veille Sanitaire, InVS), Saint-Maurice, France
- Centre de coordination de la lutte contre les infections nosocomiales (CClin) Nord, Paris, France
- Pierre et Marie Curie (Paris 6) University (EA1541), Paris, France
- The participants of these groups are listed at the end of the article
Citation style for this article: Vaux S, Carbonne A, Thiolet JM, Jarlier V, Coignard B, RAISIN and Expert Laboratories Groups. Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011 . Euro Surveill. 2011;16(22)
ii=19880. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19880 Date of submission: 17 December 2010 <HR>Emergence of carbapenemase-producing Enterobacteriaceae (CPE) is currently a major public health concern worldwide. This study showed that 53 episodes of CPE infection or colonisation have been notified by French healthcare facilities since 2004. A sharp increase in the number of notifications was observed in the last three years. Oxacillinase (OXA)-48 and Klebsiella pneumoniae carbapenemase (KPC) beta-lactamases were the most frequent enzymes reported in these episodes. The index cases in most episodes were patients with a history of hospitalisation abroad within the previous year. Around a third of the episodes (n=18) led to secondary transmission in hospitals but most of them were controlled due to reinforced measures. Reinforcement of screening and control measures at national level when there is cross-border transfer of patients, along with overall reinforcement of infection control and antimicrobial stewardship worldwide, is urgently needed to contain the spread of CPE.